Multicenter, Open-Ended, Double-Blind, Placebo-Controlled, Phase III Study of AE-941 in Addition to Combined Modality Treatment (Chemotherapy/Radiotherapy) for Locally Advanced Unresectable Non-Small Cell Lung Cancer.
Phase of Trial: Phase III
Latest Information Update: 22 Jan 2013
At a glance
- Drugs AE 941 (Primary) ; Carboplatin; Cisplatin; Paclitaxel; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 05 Jun 2007 Primary endpoint 'Overall survival' has not been met.
- 29 Aug 2005 New trial record.